MetaADEDB 2.0 @ LMMD
Diosmin
(GZSOSUNBTXMUFQ-YFAPSIMESA-N)
Structure
SMILES
COc1ccc(cc1O)c1cc(=O)c2c(o1)cc(cc2O)O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O
Type(s)
Approved; Investigational
ATC code(s)
C05CA03; C05CA53
Molecular Formula:
C28H32O15
Molecular Weight:
608.545
Log P:
-1.0897
Hydrogen Bond Acceptor:
15
Hydrogen Bond Donor:
8
TPSA:
238.2
CAS Number(s):
520-27-4
Synonym(s)
1.
Diosmin
2.
Barosmin
3.
Buchu Resin
4.
Daflon
5.
Venosmine
6.
Resin, Buchu
External Link(s)
MeSHD004145
PubChem Compound5281613
BindingDB153267
ChEBI4631
CHEMBLCHEMBL231884
DrugBankDB08995
DrugCentral3157
KEGGcpd:C10039
dr:D07858
ZINC4098512
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute Coronary SyndromeOFFSIDES
2Aldolase increasedOFFSIDES
3Arteritis obliteransOFFSIDES
4AsthmaOFFSIDES
5BlepharoptosisOFFSIDES
6Blood calcium abnormalOFFSIDES
7Blood creatine phosphokinase MB increasedOFFSIDES
8Blood creatine phosphokinase increasedOFFSIDES
9Blood fibrinogen increasedOFFSIDES
10Blood lactate dehydrogenase increasedOFFSIDES
11Blood phosphorusOFFSIDES
12Blood pressure inadequately controlledOFFSIDES
13Blood uric acidOFFSIDES
14Bone density increasedOFFSIDES
15Brain HypoxiaOFFSIDES
16CalcinosisOFFSIDES
17Cardio-respiratory distressOFFSIDES
18Cerebral atrophyOFFSIDES
19Chemical and Drug Induced Liver Injury2563116
23665045
CTD
20CholelithotomyOFFSIDES
21Cholestasis, Extrahepatic30026087CTD
22Corneal UlcerOFFSIDES
23Cytolytic hepatitisOFFSIDES
24DehydrationOFFSIDES
25Diabetes Mellitus, Experimental22056647CTD
26DiarrheaOFFSIDES
27DiplopiaOFFSIDES
28EpistaxisOFFSIDES
29Erectile dysfunctionOFFSIDES
30ErysipelasOFFSIDES
31Escherichia urinary tract infectionOFFSIDES
32FatigueOFFSIDES
33General physical health deteriorationOFFSIDES
34GranulomaOFFSIDES
35Hepatic Encephalopathy2563116CTD
36Hepatic Insufficiency30026087CTD
37HepatitisOFFSIDES
38Hepatomegaly30026087CTD
39HyperkeratosisOFFSIDES
40HyperreflexiaOFFSIDES
41HyporeflexiaOFFSIDES
42Intention tremorOFFSIDES
43IntertrigoOFFSIDES
44Joint stiffnessOFFSIDES
45Leukopenia neonatalOFFSIDES
46Limb injuryOFFSIDES
47LymphomaOFFSIDES
48Micronuclei, Chromosome-Defective25499067CTD
49Multiple SclerosisOFFSIDES
50Multiple drug overdose intentionalOFFSIDES
51Multiple sclerosis relapseOFFSIDES
52Muscle hypertrophyOFFSIDES
53Necrosis25499067CTD
54NephrolithiasisOFFSIDES
55Pancreatic InsufficiencyOFFSIDES
56ParotitisOFFSIDES
57Peripheral arterial occlusive diseaseOFFSIDES
58Perirectal abscessOFFSIDES
59PhlebitisOFFSIDES
60Popliteal pulse decreasedOFFSIDES
61Respiratory FailureOFFSIDES
62RhabdomyolysisOFFSIDES
63SigmoiditisOFFSIDES
64Silent myocardial infarctionOFFSIDES
65Transaminases increasedOFFSIDES
66Urethral StenosisOFFSIDES
67Vitamin B 12 DeficiencyOFFSIDES
68effusionOFFSIDES
69jaundice2563116CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.